Amplia Therapeutics

(ASX) ATX

Current PriceA$0.11

Market CapA$56.46M

Since IPO (2013)-94%

5 Year-56%

1 Year+83%

1 Month-27%

Amplia Therapeutics Financials at a Glance

Market Cap

A$56.46M

Revenue (TTM)

A$3.78M

Net Income (TTM)

-A$14.28M

EPS (TTM)

-A$0.02

P/E Ratio

-6.59

Dividend

A$0.00

Beta (Volatility)

0.07 (Low)

Dividend

A$0.00

Beta (Volatility)

0.07 (Low)

Price

A$0.11

Volume

970,140

Open

A$0.11

Price

A$0.11

Volume

970,140

Open

A$0.11

Previous Close

A$0.11

Daily Range

A$0.11 - A$0.12

52-Week Range

A$0.06 - A$0.43

Estimated Earnings Date

Nov 27, 2026

Dividend

A$0.00

Beta (Volatility)

0.07 (Low)

Price

A$0.11

Volume

970,140

Open

A$0.11

Previous Close

A$0.11

Daily Range

A$0.11 - A$0.12

52-Week Range

A$0.06 - A$0.43

Estimated Earnings Date

Nov 27, 2026

ATX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amplia Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Christopher J. Burns, PhD

Website

www.ampliatx.com

Headquarters

Melbourne, VIC 3000, AU

ATX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-25%

Return on Capital

-33%

Return on Assets

-19%

Earnings Yield

-15.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$56.46M

Shares Outstanding

513.31M

Volume

970.14K

Avg. Volume

4.39M

Financials (TTM)

Gross Profit

-A$92.14K

Operating Income

-A$13.18M

EBITDA

-A$13.09M

Operating Cash Flow

-A$8.73M

Capital Expenditure

-A$33.31K

Free Cash Flow

-A$8.77M

Cash & ST Invst.

A$27.85M

Total Debt

A$341.11K

Amplia Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$55.84K

-103.3%

Gross Margin

0.00%

N/A

Market Cap

A$56.46M

N/A

Market Cap/Employee

A$56.46M

N/A

Employees

N/A

Net Income

-A$3.53M

-4.6%

EBITDA

-A$6.12M

-15.7%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

A$27.85M

+722.8%

Total Debt

A$341.11K

-78.5%

Accounts Receivable

A$4.78M

+50.4%

Inventory

A$0.00

N/A

Long Term Debt

A$251.86K

+1712.8%

Short Term Debt

A$89.25K

-94.3%

Return on Assets

-18.60%

N/A

Return on Invested Capital

-33.14%

N/A

Free Cash Flow

-A$1.09M

+31.1%

Operating Cash Flow

-A$1.09M

+31.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CYP.AXCynata Therapeutics Limited

CYP.AXCynata Therapeutics LimitedA$0.26+0.00%

RAD.AXRadiopharm Theranostics Limited

RAD.AXRadiopharm Theranostics LimitedA$0.02+5.26%

M7T.AXMach7 Technologies Limited

M7T.AXMach7 Technologies LimitedA$0.30-4.76%

PTX.AXPrescient Therapeutics Limited

PTX.AXPrescient Therapeutics LimitedA$0.07-2.86%

CYC.AXCyclopharm Limited

CYC.AXCyclopharm LimitedA$0.58-2.54%

BMT.AXBeamtree Holdings Limited

BMT.AXBeamtree Holdings LimitedA$0.10-4.04%

MX1.AXMicro-X Limited

MX1.AXMicro-X LimitedA$0.04+5.71%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About ATX

What is the current price of Amplia Therapeutics?

Amplia Therapeutics is trading at A$0.11 per share.

What is the 52-week range for Amplia Therapeutics?

Over the past 52 weeks, Amplia Therapeutics has traded between A$0.06 and A$0.43.

How much debt does Amplia Therapeutics have?

As of the most recent reporting period, Amplia Therapeutics reported total debt of A$341.11K.

How much cash does Amplia Therapeutics have on hand?

Amplia Therapeutics reported A$27.85M in cash and cash equivalents in its most recent financial results.

What is Amplia Therapeutics’s dividend yield?

Amplia Therapeutics does not currently have a dividend yield.

Amplia Therapeutics

Amplia Therapeutics Financials at a Glance

ATX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Amplia Therapeutics

ATX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Amplia Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATX

What is the current price of Amplia Therapeutics?

What is the 52-week range for Amplia Therapeutics?

How much debt does Amplia Therapeutics have?

How much cash does Amplia Therapeutics have on hand?

What is Amplia Therapeutics’s dividend yield?

Premium Investing Services